Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2008 3
2009 1
2010 5
2011 2
2013 1
2014 2
2015 5
2016 2
2017 4
2018 6
2019 7
2020 15
2021 9
2022 9
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hiromatsu iida[Author] (3 results)?
Oral Kaposi sarcoma following cord blood transplantation.
Imahashi N, Arakawa M, Iwakoshi A, Mori M, Nagai H, Iida H. Imahashi N, et al. Among authors: iida h. EJHaem. 2022 Jan 24;3(2):569-570. doi: 10.1002/jha2.387. eCollection 2022 May. EJHaem. 2022. PMID: 35846045 Free PMC article. No abstract available.
Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study.
Nishiwaki S, Sugiura I, Sato T, Kobayashi M, Osaki M, Sawa M, Adachi Y, Okabe M, Saito S, Morishita T, Kohno A, Nishiyama T, Iida H, Kurahashi S, Kuwatsuka Y, Sugiyama D, Ito S, Nishikawa H, Kiyoi H. Nishiwaki S, et al. Among authors: iida h. EJHaem. 2023 Mar 20;4(2):358-369. doi: 10.1002/jha2.677. eCollection 2023 May. EJHaem. 2023. PMID: 37206256 Free PMC article.
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
Asada N, Ando J, Takada S, Yoshida C, Usuki K, Shinagawa A, Ishizawa K, Miyamoto T, Iida H, Dobashi N, Okubo S, Honda H, Soshin T, Nishimura Y, Tsutsui A, Mukai H, Yamamoto K. Asada N, et al. Among authors: iida h. Jpn J Clin Oncol. 2023 Jun 29;53(7):595-603. doi: 10.1093/jjco/hyad027. Jpn J Clin Oncol. 2023. PMID: 37017320 Free PMC article. Clinical Trial.
Enlarging mediastinal/hilar lymphadenopathy with calcification.
Adachi T, Nakahata M, Moritani S, Iida H, Ogawa K. Adachi T, et al. Among authors: iida h. Clin Case Rep. 2015 Dec 9;4(2):212-3. doi: 10.1002/ccr3.451. eCollection 2016 Feb. Clin Case Rep. 2015. PMID: 26862422 Free PMC article.
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Murakami S, Ri M, Ito M, Nakamura N, Kasahara S, Kitagawa J, Inagaki Y, Kuroda J, Yoshimitsu M, Okamoto A, Fukuhara N, Taji H, Iida H, Nagai H, Hanamura I, Tsujimura H, Okura M, Kurata M, Kuwatsuka Y, Atsuta Y, Iida S. Murakami S, et al. Among authors: iida h. Int J Hematol. 2022 Oct;116(4):563-569. doi: 10.1007/s12185-022-03379-9. Epub 2022 Jun 14. Int J Hematol. 2022. PMID: 35699890
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.
Hosono N, Yokoyama H, Aotsuka N, Ando K, Iida H, Ishikawa T, Usuki K, Onozawa M, Kizaki M, Kubo K, Kuroda J, Kobayashi Y, Shimizu T, Chiba S, Nara M, Hata T, Hidaka M, Fujiwara SI, Maeda Y, Morita Y, Kusano M, Lu Q, Miyawaki S, Berrak E, Hasabou N, Naoe T. Hosono N, et al. Among authors: iida h. Int J Clin Oncol. 2021 Nov;26(11):2131-2141. doi: 10.1007/s10147-021-02006-7. Epub 2021 Aug 7. Int J Clin Oncol. 2021. PMID: 34363558 Free PMC article. Clinical Trial.
68 results